Virus protease: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 42: | Line 42: | ||
**[[2b7f]] – HTLV-PV + peptide<br /> | **[[2b7f]] – HTLV-PV + peptide<br /> | ||
**[[3lin]] – HTLV-PV (mutant) + inhibitor<br /> | **[[3lin]], [[3liq]], [[3lit]], [[3liv]], [[3lix]], [[3liy]], [[4ydg]], [[4ydf]] – HTLV-PV (mutant) + inhibitor<br /> | ||
*'''Rous sarcoma virus protease''' | *'''Rous sarcoma virus protease''' | ||
**[[1bai]] – RSVP + polypeptide inhibitor | **[[2rsp]] – RSVP - Rous sarcoma virus<br/> | ||
**[[1bai]] – RSVP + polypeptide inhibitor | |||
*'''Human Cytomegalovirus protease''' | *'''Human Cytomegalovirus protease''' | ||
**[[1cmv]], [[1lay]] – CMVP (mutant) | **[[1wpo]] – CMVP - human herpes virus 5<br /> | ||
**[[ | **[[1cmv]], [[1lay]], [[1jq6]], [[1id4]], [[1iec]], [[1ied]], [[1ief]], [[1ieg]] – CMVP (mutant) <br /> | ||
**[[ | **[[2wpo]], [[1jq7]] - CMVP (mutant) + inhibitor<br /> | ||
**[[1njt]], [[1nju]], [[1nkk]], [[1nkm]] - CMVP (mutant) + peptide inhibitor<br /> | |||
*'''Varicella-Zoster virus protease''' | *'''Varicella-Zoster virus protease''' | ||
| Line 60: | Line 62: | ||
*'''Equine infectious anemia virus protease''' | *'''Equine infectious anemia virus protease''' | ||
**[[2fmb]] – EIAVP (mutant) + inhibitor | **[[2fmb]], [[1fmb]] – EIAVP (mutant) + inhibitor | ||
*'''Hepatitis A virus protease''' | *'''Hepatitis A virus protease''' | ||
**[[2h9h]] – HAVP residues 1520-1731 (mutant) + polypeptide inhibitor | **[[2h9h]], [[2hal]] – HAVP residues 1520-1731 (mutant) + polypeptide inhibitor | ||
*'''Hepatitis C virus protease''' | *'''Hepatitis C virus protease''' | ||
**[[2o8m]] – HCVP (mutant)<br /> | **[[2o8m]] – HCVP (mutant)<br /> | ||
**[[2a4g]], [[2gvf]], [[2f9u]], [[2f9v]] – HCVP + peptide inhibitor<br /> | |||
*'''Orf 17''' | *'''Orf 17''' | ||
| Line 78: | Line 81: | ||
**[[3u1i]] – DvNs2b + peptide – Dengue virus<br /> | **[[3u1i]] – DvNs2b + peptide – Dengue virus<br /> | ||
**[[3u1j]] – DvNs2b + BPTI<br /> | **[[3u1j]] – DvNs2b + BPTI<br /> | ||
**[[2fom]] - DvNs2b + DvNs3<br /> | **[[2fom]] - DvNs2b/DvNs3<br /> | ||
**[[2whx]] – DvNs3 residues 1475-2092 | **[[4m9f]], [[4m9i]], [[4m9k]], [[4m9m]], [[3lkw]] - DvNs2b/DvNs3 (mutant)<br /> | ||
**[[4m9t]] - DvNs2b/DvNs3 (mutant) + inhibitor<br /> | |||
**[[2jlq]] – DvNs3 residues 1646-2092 <br /> | |||
**[[2jlv]] – DvNs3 residues 1646-2092 + AMPPNP + RNA<br /> | |||
**[[2jlr]] – DvNs3 residues 1646-2092 + AMPPNP<br /> | |||
**[[2jls]] – DvNs3 residues 1646-2092 + ADP<br /> | |||
**[[2jlx]], [[2jly]], [[2jlz]] – DvNs3 residues 1646-2092 + ADP + RNA<br /> | |||
**[[2jlu]], [[2jlw]] – DvNs3 residues 1646-2092 + RNA<br /> | |||
**[[2vbc]], [[2whx]], [[2wzq]] – DvNs3 residues 1475-2092 + peptide inhibitor<br /> | |||
**[[2m9p]], [[2m9q]] – DvNs3 residues 1475-1648 + peptide inhibitor - NMR<br /> | |||
*'''Herpes simplex virus protease''' | *'''Herpes simplex virus protease''' | ||
Revision as of 22:59, 5 October 2018
| ||||||||||||
3D Structures of Virus proteases
Updated on 05-October-2018
- Simian Immunodeficiency virus protease See HIV Protease Inhibitor Pharmacokinetics
- Xenotropic murine leukemia virus protease
- HIV Protease Inhibitor Resistance Profile – XMRV-PR P14
- HIV Protease Resistance – XMRV-PR RNase H domain (mutant)
- Molecular Playground/Dengue Virus Protease – XMRV-PR residues 533-657 + inhibitor
- Viability of a drug-resistant HIV-1 protease mutant – XMRV-PR residues 533-657 + pepstatin
- Molecular Playground/Dengue Virus Protease – XMRV-PR residues 533-657 + amprenavir
- HIV Protease Inhibitor Resistance Profile – XMRV-PR P14
- Human T-cell leukemia virus protease
- Rous sarcoma virus protease
- Human Cytomegalovirus protease
- Varicella-Zoster virus protease
- 1vzv - VZVP (mutant) – human herpes virus
- Equine infectious anemia virus protease
- Hepatitis A virus protease
- Hepatitis C virus protease
- Orf 17
- 3njq – hOrf 17 - human herpes virus 8
- Dengue virus protease
- 3u1i – DvNs2b + peptide – Dengue virus
- 3u1j – DvNs2b + BPTI
- 2fom - DvNs2b/DvNs3
- 4m9f, 4m9i, 4m9k, 4m9m, 3lkw - DvNs2b/DvNs3 (mutant)
- 4m9t - DvNs2b/DvNs3 (mutant) + inhibitor
- 2jlq – DvNs3 residues 1646-2092
- 2jlv – DvNs3 residues 1646-2092 + AMPPNP + RNA
- 2jlr – DvNs3 residues 1646-2092 + AMPPNP
- 2jls – DvNs3 residues 1646-2092 + ADP
- 2jlx, 2jly, 2jlz – DvNs3 residues 1646-2092 + ADP + RNA
- 2jlu, 2jlw – DvNs3 residues 1646-2092 + RNA
- 2vbc, 2whx, 2wzq – DvNs3 residues 1475-2092 + peptide inhibitor
- 2m9p, 2m9q – DvNs3 residues 1475-1648 + peptide inhibitor - NMR
- 3u1i – DvNs2b + peptide – Dengue virus
- Herpes simplex virus protease
- 1at3 – HSV II – human herpesvirus 2
- Foot-and-Mouth Disease virus protease
- 2bhg – FMDV – Foot-and-mouth disease virus
- Infectious Bronchitis virus protease
- Yellowtail ascites virus protease
- Pseudorabies virus protease
- 4cx8 – YAV – pseudorabies virus
- 4cx8 – YAV – pseudorabies virus
References
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman
